Cited by 3,605Angiogenesis and VEGF in CancerLymphatic System and DiseasesCancer, Hypoxia, and Metabolism

The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Kim, K. Jin, Li, Bing, Winer, Jane, Armanini, Mark, Gillett, Nancy, Phillips, Heidi S., Ferrara, Napoleone·1993·Nature

Open this paper in CoChat — free account

Abstract

The development of new blood vessels (angiogenesis) is required for many physiological processes including embryogenesis, wound healing and corpus luteum formation. Blood vessel neoformation is also important in the pathogenesis of many disorders, particularly rapid growth and metastasis of solid tumours. There are several potential mediators of tumour angiogenesis, including basic and acidic fibroblast growth factors, tumour necrosis factor-alpha and transforming factors-alpha and -beta. But it is unclear whether any of these agents actually mediates angiogenesis and tumour growth in vivo. Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen and an angiogenesis inducer released by a variety of tumour cells and expressed in human tumours in situ. To test whether VEGF may be a tumour angiogenesis factor in vivo, we injected human rhabdomyosarcoma, glioblastoma multiforme or leiomyosarcoma cell lines into nude mice. We report here that treatment with a monoclonal antibody specific for VEGF inhibited the growth of the tumours, but had no effect on the growth rate of the tumour cells in vitro. The density of vessels was decreased in the antibody-treated tumours. These findings demonstrate that inhibition of the action of an angiogenic factor spontaneously produced by tumour cells may suppress tumour growth in vivo.

Integrity signals

Registry

Crossref · 10.1038/362841a0

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,598
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 5,000
Self-citation
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,509
Angiogenesis.
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,651
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,269
Self-citation
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,262
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G. G., Sanzo, K., Warren, T. G., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,058
The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,988
Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
Ferrara, N., Houck, K. A., Jakeman, L. B., & LEUNG, D. W. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-18 · Cited by 1,655
Self-citation

Flagged first, then by citations

Show all 32 references

1 of the 32 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Senger, D., Perruzzi, C. A., Feder, J. & Dvorak, H. F. Cancer Res. 46, 5629 (1986).
Westphal, M. et al. Expl cell. Biol. 55, 152–161 (1987).

Sorted by citations

Items 501–600 of 1,006

The VEGF family in cancer and antibody-based strategies for their inhibition
Sullivan, L. A., & Brekken, R. A. (2010) · mAbs · doi:10.4161/mabs.2.2.11360 · Cited by 184
The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review
Ribatti, D. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05291.x · Cited by 184
Role of the VEGF/VEGFR Axis in Cancer Biology and Therapy
Rapisarda, A., & Melillo, G. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-386503-8.00006-5 · Cited by 186
Expression and distribution of vascular endothelial growth factor protein in human brain tumors
Pietsch, T., Valter, M. M., Wolf, H. K., von Deimling, A., Huang, H., Cavenee, W. K., & Wiestler, O. D. (1997) · Acta Neuropathologica · doi:10.1007/s004010050591 · Cited by 180
Regional Suppression of Tumor Growth by In Vivo Transfer of a cDNA Encoding a Secreted Form of the Extracellular Domain of the flt-1 Vascular Endothelial Growth Factor Receptor
Kong, H.-L., Hecht, D., Song, W., Kovesdi, I., Hackett, N. R., Yayon, A., & Crystal, R. G. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.6-823 · Cited by 179
TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function.
Behzadian, M. A., Wang, X. L., Windsor, L. J., Ghaly, N., & Caldwell, R. B. (2001) · PubMed · Cited by 179
In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells
Chen, H., Treweeke, A., West, D. C., Till, K. J., Cawley, J. C., Zuzel, M., & Toh, C. (2000) · Blood · doi:10.1182/blood.v96.9.3181 · Cited by 179
Hypoxic Regulation of Vascular Endothelial Growth Factor mRNA Stability Requires the Cooperation of Multiple RNA Elements
Dibbens, J. A., Miller, D. L., Damert, A., Risau, W., Vadas, M. A., & Goodall, G. J. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.907 · Cited by 185
VEGF–integrin interplay controls tumor growth and vascularization
De, S., Razorenova, O. V., McCabe, N. P., O’Toole, T. E., Qin, J., & Byzova, T. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502935102 · Cited by 178
Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer
Patel, J. D., Hensing, T. A., RADEMAKER, A. W., Hart, E. M., Blum, M. G., Milton, D. T., & Bonomi, P. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8181 · Cited by 178
Calreticulin and Calreticulin Fragments Are Endothelial Cell Inhibitors That Suppress Tumor Growth
Pike, S. E., Yao, L., Setsuda, J., Jones, K. D., Cherney, B., Appella, E., Sakaguchi, K., Nakhasi, H. L., Atreya, C. D., Teruya‐Feldstein, J., et al. (1999) · Blood · doi:10.1182/blood.v94.7.2461.419a26_2461_2468 · Cited by 177
VEGF-VEGFR Signals in Health and Disease
Shibuya, M. (2014) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2013.113 · Cited by 183
Silibinin Inhibits Colorectal Cancer Growth by Inhibiting Tumor Cell Proliferation and Angiogenesis
Singh, R. P., Gu, M., & Agarwal, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6247 · Cited by 176
Expression of Vascular Endothelial Growth Factor and Its Receptors in the Anaplastic Progression of Astrocytoma, Oligodendroglioma, and Ependymoma
Chan, A. S. Y., Leung, S. Y., Wong, M. P., Yuen, S. T., Cheung, N., Fan, Y. W., & Chung, L.-P. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199807000-00004 · Cited by 176
Targeting VEGF in eye neovascularization: What's new?
Amadio, M., Govoni, S. M., & Pascale, A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.027 · Cited by 180
Serum vascular endothelial growth factor is often elevated in disseminated cancer.
Salvén, P., Mänpää, H., Orpana, A., Alitalo, K. K., & Joensuu, H. (1997) · PubMed · Cited by 176
Pathways for aberrant angiogenesis in pancreatic cancer.
Korc, M. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-8 · Cited by 179
Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys
Tucker, C. E., Chen, L.-S., Judkins, M. B., Farmer, J. A., Gill, S. C., & Drolet, D. W. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(99)00285-6 · Cited by 175
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis
Jubb, A. M., Buffa, F. M., & Harris, A. L. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00944.x · Cited by 175
Eag1 Expression Interferes with Hypoxia Homeostasis and Induces Angiogenesis in Tumors
Downie, B., Sánchez, A., Knötgen, H., Contreras‐Jurado, C., Gymnopoulos, M., Weber, C., Stühmer, W., & Pardo, L. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801830200 · Cited by 175
Heat Shock Proteins Regulatory Role in Neurodevelopment
Miller, D. J., & Fort, P. E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00821 · Cited by 185
Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer
Hyodo, I., Doi, T., Endo, H., Hosokawa, Y., Nishikawa, Y., Tanimizu, M., Jinno, K., & Kotani, Y. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00282-2 · Cited by 175
Receptor Tyrosine Kinase-Mediated AngiogenesisPreprint
Jeltsch, M., Leppänen, V., Saharinen, P., & Alitalo, K. K. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009183 · Cited by 180
Pelvic Ewing sarcoma
Hoffmann, C., Ahrens, S., Dunst, J., Hillmann, A., Winkelmann, W., Craft, A. W., G�bel, U., R�be, C., te, P. A. V., Harms, D., et al. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990215)85:4 · Cited by 101
Signaling angiogenesis and lymphangiogenesis
Korpelainen, E., & Alitalo, K. K. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80137-3 · Cited by 171
Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas
Desjardins, A., Reardon, D. A., Herndon, J. E., Marcello, J. E., Quinn, J. A., Rich, J. N., Sathornsumetee, S., Gururangan, S., Sampson, J. H., Bailey, L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0260 · Cited by 173
VEGF/VEGFR signalling as a target for inhibiting angiogenesis
Kiselyov, A. S., Balakin, K. V., & Tkachenko, S. E. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.1.83 · Cited by 176
At What Cost Does a Potential Survival Advantage of Bevacizumab Make Sense for the Primary Treatment of Ovarian Cancer? A Cost-Effectiveness Analysis
Cohn, D. E., Kim, K. H., Resnick, K. E., O’Malley, D. M., & Straughn, J. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.1075 · Cited by 175
Self-citation
Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma.
Tanigawa, N., Amaya, H., Matsumura, M., & Shimomatsuya, T. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.826 · Cited by 172
Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome.
Levin, E. R., Rosen, G. F., Cassidenti, D. L., Yee, B., Meldrum, D. R., Wisot, A. L., & Pedram, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4814 · Cited by 172
VEGF blocking therapy in the treatment of cancer
Bender, J. G., Kandel, J. J., & Yamashiro, D. J. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.2.263 · Cited by 172
Characterization of protein kinase C β isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization
Suzuma, K., Takahara, N., Suzuma, I., Isshiki, K., Ueki, K., Leitges, M., Aiello, L. P., & King, G. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022644499 · Cited by 170
Refractoriness to Antivascular Endothelial Growth Factor Treatment: Role of Myeloid Cells
Shojaei, F., & Ferrara, N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0925 · Cited by 172
Self-citation
Drug resistance, predictive markers and pharmacogenomics in colorectal cancer
Longley, D. B., Allen, W. L., & Johnston, P. G. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.001 · Cited by 173
Response-Independent Survival Benefit in Metastatic Colorectal Cancer: A Comparative Analysis of N9741 and AVF2107
Grothey, A. F., Hedrick, E. E., MASS, R. D., Sarkar, S., Suzuki, S., Ramanathan, R. K., Hurwitz, H. I., Goldberg, R. M., & Sargent, D. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8099 · Cited by 171
Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
Niu, Z., Jin, R., Zhang, Y., & Li, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01200-x · Cited by 185
Age-related changes in the temporal and spatial distributions of fibrillin and elastin mRNAS and proteins in acute cutaneous wounds of healthy humans
Ashcroft, G. S., Kielty, C. M., Horan, M. A., & Ferguson, M. W. J. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199709)183:1 · Cited by 84
The Role of the Vascular Phase in Solid Tumor Growth: A Historical Review
Ribatti, D., Vacca, A., & Dammacco, F. (1999) · Neoplasia · doi:10.1038/sj.neo.7900038 · Cited by 169
Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma
Imoto, H., Osaki, T., Taga, S., Ohgami, A., Ichiyoshi, Y., & Yasumoto, K. (1998) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70398-8 · Cited by 171
Vascular Endothelial Growth Factor Enhances Endothelial Cell Survival and Tumor Radioresistance
Gupta, V. K., Jaskowiak, N. T., Beckett, M. A., Mauceri, H. J., Grunstein, J., Johnson, R. S., Calvin, D. A., Nodzenski, E., Pejovic, M., Kufe, D. W., et al. (2002) · The Cancer Journal · doi:10.1097/00130404-200201000-00009 · Cited by 169
Identification of Tyrosine Residues in Vascular Endothelial Growth Factor Receptor-2/FLK-1 Involved in Activation of Phosphatidylinositol 3-Kinase and Cell Proliferation
Dayanir, V., Meyer, R., Lashkari, K., & Rahimi, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009128200 · Cited by 172
The multiple roles of tumour stroma
Wernert, N. (1997) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050053 · Cited by 171
Circulating VEGF Levels in the Serum of Gastric Cancer Patients
Karayiannakis, A. J., Syrigos, K. N., Polychronidis, A., Zbar, A. P., Kouraklis, G. P., Simopoulos, C. E., & Karatzas, G. (2002) · Annals of Surgery · doi:10.1097/00000658-200207000-00007 · Cited by 169
Apelin is a potent activator of tumour neoangiogenesis
Sorli, S., Gonidec, S. L., Knibiehler, B., & Audigier, Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210573 · Cited by 171
The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers.
O’Brien, T., Cranston, D., Fuggle, S., Bicknell, R., & Harris, A. L. (1996) · PubMed · Cited by 168
Angiogenesis in epithelian ovarian cancer
Bamberger, E. S., & Perrett, C. W. (2002) · Molecular Pathology · doi:10.1136/mp.55.6.348 · Cited by 171
Inhibition of NF-κB Activity Decreases the VEGF mRNA Expression in MDA-MB-231 Breast Cancer Cells
Shibata, A., Nagaya, T., Imai, T., Funahashi, H., Nakao, A., & Seo, H. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1015872531675 · Cited by 168
The Biochemistry of Cancer Dissemination
Price, J. T., Bonovich, M. T., Kohn, E. C., Welch, D. R., & Hershey, M. S. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709082573 · Cited by 169
Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer
Anan, K., Morisaki, T., Katano, M., Ikubo, A., Kitsuki, H., Uchiyama, A., Kuroki, S., Tanaka, M., & Torisu, M. (1996) · Surgery · doi:10.1016/s0039-6060(96)80120-6 · Cited by 167
CCL3-CCR5 Axis Regulates Intratumoral Accumulation of Leukocytes and Fibroblasts and Promotes Angiogenesis in Murine Lung Metastasis Process
Wu, Y., Li, Y.-Y., Matsushima, K., Baba, T., & Mukaida, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6384 · Cited by 171
Targeted Nanoparticles for Colorectal Cancer
Cisterna, B. A., Kamaly, N., Choi, W. I., Tavakkoli, A., Farokhzad, O. C., & Vilos, C. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0194 · Cited by 174
Role of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptors in Vascular Development
Carmeliet, P., & Collen, D. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59953-8_7 · Cited by 173
Periostin: novel diagnostic and therapeutic target for cancer.
Kudo, Y., Siriwardena, B. S. M. S., Hatano, H., Ogawa, I., & Takata, T. (2007) · PubMed · doi:10.14670/hh-22.1167 · Cited by 166
Brain Edema in Meningiomas Is Associated with Increased Vascular Endothelial Growth Factor Expression
Goldman, C. K., Bharara, S., Palmer, C. A., Vitek, J. J., Tsai, J., Weiss, H. L., & Gillespie, G. Y. (1997) · Neurosurgery · doi:10.1097/00006123-199706000-00029 · Cited by 165
Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma
Cascone, T., Herynk, M. H., Xu, L., Du, Z., Kadara, H. N., Nilsson, M. B., Oborn, C. J., Park, Y., Erez, B., Jacoby, J. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42405 · Cited by 166
Bevacizumab Has Differential and Dose-Dependent Effects on Glioma Blood Vessels and Tumor Cells
von Baumgarten, L., Brucker, D., Tirniceru, A., Kienast, Y., Grau, S. J., Burgold, S., Herms, J. W., & Winkler, F. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1868 · Cited by 164
Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants
Neufeld, G., Cohen, T., Gitay-Goren, H., Gluzman‐Poltorak, Z., Tessler, S., Sharon, R., Gengrinovitch, S., & Levi, B.-Z. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437467 · Cited by 164
VEGF-B promotes cancer metastasis through a VEGF-A–independent mechanism and serves as a marker of poor prognosis for cancer patients
Yang, X., Zhang, Y., Hosaka, K., Andersson, P., Wang, J., Tholander, F., Cao, Z., Morikawa, H., Tegner, J. N., Yang, Y., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503500112 · Cited by 164
Synergy between tumor immunotherapy and antiangiogenic therapy
Nair, S. K., Boczkowski, D., Moeller, B. J., Dewhirst, M. W., Vieweg, J., & Gilboa, E. (2003) · Blood · doi:10.1182/blood-2002-12-3738 · Cited by 163
Targeting the DNA Damage Response in Cancer
Ljungman, M. E. (2009) · Chemical Reviews · doi:10.1021/cr900047g · Cited by 164
Seminal and molecular evidence that sauna exposure affects human spermatogenesis
Garolla, A., Torino, M., Sartini, B., Cosci, I., Patassini, C., Carraro, U., & Foresta, C. (2013) · Human Reproduction · doi:10.1093/humrep/det020 · Cited by 163
VEGF/VPF: The angiogenesis factor found?
Klagsbrun, M., & Söker, S. (1993) · Current Biology · doi:10.1016/0960-9822(93)90073-w · Cited by 165
Design and Synthesis of Imidazopyridine Analogues as Inhibitors of Phosphoinositide 3-Kinase Signaling and Angiogenesis
Kim, O., Jeong, Y., Lee, H., Hong, S.-S., & Hong, S. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101582z · Cited by 162
NEUTRALIZING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIBODY INHIBITS FURTHER GROWTH OF ESTABLISHED PROSTATE CANCER AND METASTASES IN A PRE-CLINICAL MODEL
Melnyk, O. O., ZIMMERMAN, M., KIM, K. J., & Shuman, M. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61829-9 · Cited by 162
Self-citation
Clinical implications of growth factors in flexor tendon wound healing
Hsu, C., & Chang, J. (2004) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2004.04.020 · Cited by 160
Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin
Czubayko, F., Schulte, A. M., Berchem, G., & Wellstein, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14753 · Cited by 162
A Review of VEGF/VEGFR-Targeted Therapeutics for Recurrent Glioblastoma
Reardon, D. A., Turner, S., Peters, K. B., Desjardins, A., Gururangan, S., Sampson, J. H., McLendon, R. E., Herndon, J. E., Jones, L. W., Kirkpatrick, J. P., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0038 · Cited by 160
Vascular Endothelial Growth Factor Immunoneutralization Plus Paclitaxel Markedly Reduces Tumor Burden and Ascites in Athymic Mouse Model of Ovarian Cancer
Hu, L., Hofmann, J., Zaloudek, C. J., Ferrara, N., Hamilton, T. C., & Jaffe, R. B. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64467-7 · Cited by 161
Self-citation
Anti‐VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases
Ng, E. W. M., & Adamis, A. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.062 · Cited by 160
Resveratrol and breast cancer chemoprevention: Molecular mechanisms
Corre, L. L., Chalabi, N., Delort, L., Bignon, Y., & Bernard-Gallon, D. J. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400094 · Cited by 162
MicroRNAs: Opening a New Vein in Angiogenesis Research
Fish, J. E., & Srivastava, D. (2009) · Science Signaling · doi:10.1126/scisignal.252pe1 · Cited by 160
Tumor angiogenesis – A potential target in cancer chemoprevention
Bhat, T. A., & Singh, R. P. (2007) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.08.032 · Cited by 159
The basic helix-loop-helix transcription factor, dHAND, is required for vascular development
Yamagishi, H., Olson, E. N., & Srivastava, D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8856 · Cited by 162
Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors.
Pavco, P. A., Bouhana, K., Gallegos, A. M., Agrawal, A., Blanchard, K. S., Grimm, S., Jensen, K. L., Andrews, L. E., Wincott, F. E., PITOT, P. A., et al. (2000) · PubMed · Cited by 160
Anti‐angiogenic drugs: from bench to clinical trials
Quesada, A. R., Muñoz‐Chápuli, R., & Medina, M. Á. (2006) · Medicinal Research Reviews · doi:10.1002/med.20059 · Cited by 159
Detection and Quantification of Vascular Endothelial Growth Factor/Vascular Permeability Factor in Brain Tumor Tissue and Cyst Fluid
Weindel, K., Moringlane, J. R., Marmé, D., & Weich, H. A. (1994) · Neurosurgery · doi:10.1227/00006123-199409000-00012 · Cited by 161
Transforming Growth Factor β1 Down-regulates Vascular Endothelial Growth Factor Receptor 2/flk-1 Expression in Vascular Endothelial Cells
Mandriota, S. J., Menoud, P.-A., & Pepper, M. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11500 · Cited by 160
The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy
Tal, R., & Segars, J. H. (2013) · Human Reproduction Update · doi:10.1093/humupd/dmt042 · Cited by 159
Angiogenin antagonists prevent tumor growth in vivo.
Olson, K. A., Fett, J. W., French, T. C., Key, M. E., & Vallée, B. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.442 · Cited by 159
Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix
Loncaster, J. A., Cooper, R., Logue, J. P., Davidson, S. E., Hunter, R. D., & West, C. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1319 · Cited by 159
Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity
Zhu, Z., Hattori, K., Zhang, H., Jimenez, X., Ludwig, D. L., Dias, S., Kussie, P. H., Koo, H., Kim, H. J., Lü, D., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402831 · Cited by 158
Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy
Wood, L. M., & Paterson, Y. Y. W. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00051 · Cited by 163
Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis
Peters, K. G., Coogan, A., Berry, D., Marks, J., Iglehart, J. D., Kontos, C. D., Rao, P., Sankar, S., & Trogan, E. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.8 · Cited by 157
Effect of VEGF receptor inhibitor PTK787/ZK222548 combined with ionizing radiation on endothelial cells and tumour growth
Hess, C. F., Vuong, V., Hegyi, I., Riesterer, O., Wood, J. M., Fabbro, D., Glanzmann, C., Bodis, S. B., & Pruschy, M. N. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2166 · Cited by 157
Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets
Nagy, J. A., & Dvorak, H. F. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9500-6 · Cited by 163
Vascular Endothelial Growth Factor Expression Is Higher in Differentiated Thyroid Cancer than in Normal or Benign Thyroid1
Soh, E. Y., Duh, Q., Sobhi, S. A., Young, D. M., Epstein, H. D., Wong, M. G., Garcia, Y. K., Min, Y. D., Grossman, R. F., SIPERSTEIN, A. E., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4340 · Cited by 154
Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells
Drexler, H. C. A., Risau, W., & Konerding, M. A. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.65 · Cited by 155
Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth
Fujita, M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh324 · Cited by 156
Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines.
Senger, D. R. (1996) · Europe PMC (PubMed Central) · Cited by 156
c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis
Shimizu, T., Ishikawa, T., Sugihara, E., Kuninaka, S., Miyamoto, T., Mabuchi, Y., Matsuzaki, Y., Tsunoda, T., Miya, F., Morioka, H., et al. (2010) · Oncogene · doi:10.1038/onc.2010.312 · Cited by 158
Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart
Su, H., Lu, R., & Kan, Y. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250488097 · Cited by 155
Increased Expression of Angiogenic Factors in Human Colonic Angiodysplasia
Junquera, F., Saperas, E., de Torres, I. M., Vidal, M. T., & Malagelada, J. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00072-6 · Cited by 153
PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth
Bais, C., Wu, X., Yao, J. J., Yang, S., Crawford, Y., McCutcheon, K. M., Tan, C., Kolumam, G. A., Vernes, J.-M., Eastham‐Anderson, J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.033 · Cited by 159
Self-citation
A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models
Brown, J. L., Cao, Z. A., Pinzon-Ortiz, M. C., Kendrew, J., Reimer, C., Wen, S., Zhou, J. Q., Tabrizi, M. A., Emery, S. C., McDermott, B., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0554 · Cited by 154
Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome.
Hawighorst, H., Weikel, W., Knapstein, P. G., Knopp, M. V., ZUNA, I., Schönberg, S., Vaupel, P. W., & KAICK, G. V. (1998) · PubMed · Cited by 154
The Biological Processes During Wound Healing
Yang, F., Bai, X., Dai, X., & Li, Y. (2021) · Regenerative Medicine · doi:10.2217/rme-2020-0066 · Cited by 165
Activation of the Tie2 Receptor by Angiopoietin-1 Enhances Tumor Vessel Maturation and Impairs Squamous Cell Carcinoma Growth
Hawighorst, T., Skobe, M., Streit, M., Hong, Y., Velasco, P., Brown, L. F., Riccardi, L., Lange‐Asschenfeldt, B., & Detmar, M. J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62565-5 · Cited by 153
Dynamic contrast‐enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti‐angiogenic therapy in a xenograft model of glioblastoma multiforme
Goßmann, A., Helbich, T. H., Kuriyama, N., Ostrowitzki, S., Roberts, T. P. L., Shames, D. M., van Bruggen, N., Wendland, M. F., Israel, M. A., & Brasch, R. C. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10072 · Cited by 151
Single-Nucleotide Polymorphisms of Vascular Endothelial Growth Factor in Psoriasis of Early Onset
Young, H. S., Bhushan, M., Griffiths, C. E. M., Summers, A., & Brenchley, P. E. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2003.22107.x · Cited by 153
PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma
Liu, T., Ma, W., Xu, H., Huang, M., Zhang, D., He, Z., Zhang, L., Brem, S. S., O’Rourke, D. M., Gong, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05982-z · Cited by 162

Authors: Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N.
Affiliations: Genentech (US)
ORCID: Li, Bing
Armanini, Mark
Phillips, Heidi S.
Ferrara, Napoleone
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1993-04
Volume: 362
Issue: 6423
Pages: 841-844
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/362841a0
OpenAlex: W1969328947
Cited by: 3,605
References: 32
Citations by year: 2026: 22 · 2025: 25 · 2024: 43 · 2023: 47 · 2022: 53 · 2021: 55 · 2020: 55 · 2019: 54 · 2018: 89 · 2017: 101 · 2016: 81 · 2015: 78 · 2014: 98 · 2013: 110 · 2012: 137
FWCI: 32.75
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords: vascular endothelial growth factor, angiogenesis, tumor angiogenesis, tumor growth inhibition, monoclonal antibodies, rhabdomyosarcoma, glioblastoma, leiomyosarcoma, tumor vasculature, nude mice, tumour metastasis
MeSH terms: Animals, Antibodies, Monoclonal, Cell Division, Female, Glioblastoma, Humans, Leiomyosarcoma, Lymphokines, Mice, Nude, Neoplasm Transplantation, Neoplasms, Experimental, Neovascularization, Pathologic, Rhabdomyosarcoma, Tumor Cells, Cultured, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks